GAINESVILLE, Fla. -- (BUSINESS WIRE) -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that it will conduct an intercontinental medical education course in shoulder arthroplasty to be held simultaneously in Rio de Janeiro, Brazil and Venice, Italy, on April 3-4, 2014.
The program will include a broadcast of live surgery, panel discussions and presentations on clinical outcomes, new biomechanical insights and guidance on surgical techniques designed for the experienced shoulder surgeon.
More than 100 surgeons will participate in programs conducted simultaneously in Brazil and Italy. They will attend presentations and interact with others at their respective venues, as well as participating in presentations and discussions broadcast from each location. A live shoulder surgery performed in Italy will also be part of the international broadcast and discussion.
“The enthusiastic embrace of our last two masters courses and the ever-increasing interest in our Equinoxe® shoulder system led us to explore ways we can further broaden our reach to meet the needs of shoulder surgeons around the globe,” said Darin Johnson, VP of Marketing, Extremities & Hips.
“Surgeons thrive on learning from world renowned faculty from diverse backgrounds and locations. This is an exciting new format that allows surgeons to benefit from two outstanding programs and faculty teams at once,” he said. “Exactech is known for our innovation in implant and instrumentation design, so it only follows that we would also leverage the latest technologies for our medical education programs.”
The program addresses the strong demand for advanced medical education in total shoulder arthroplasty, reverse shoulder arthroplasty and trauma, and interest in the company’s Equinoxe shoulder, which for several years has been the fastest growing shoulder system in the industry.
Exactech’s complete calendar of medical education opportunities is available at www.exac.com/EME.
Exactech develops and markets orthopaedic implant devices, related surgical instruments and biologic materials and services to hospitals and physicians. The company manufactures many of its orthopaedic devices at its Gainesville facility. Exactech’s orthopaedic products are used in the restoration of bones and joints that have deteriorated as a result of injury or diseases such as arthritis. Exactech markets its products in the United States, in addition to more than 30 markets in Europe, Latin America, Asia and the Pacific. Additional information about Exactech, Inc. can be found at http://www.exac.com. Copies of Exactech’s press releases, SEC filings, current price quotes and other valuable information for investors may be found at http://www.exac.com and http://www.hawkassociates.com.
This release contains various forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which represent the company’s expectations or beliefs concerning future events of the company’s financial performance. These forward-looking statements are further qualified by important factors that could cause actual results to differ materially from those in the forward-looking statements. These factors include the effect of competitive pricing, the company’s dependence on the ability of third party manufacturers to produce components on a basis which is cost-effective to the company, market acceptance of the company’s products and the effects of government regulation. Results actually achieved may differ materially from expected results included in these statements.